468 related articles for article (PubMed ID: 23719559)
21. Upregulation of Intestinal NLRP6 Inflammasomes After Roux-en-Y Gastric Bypass Promotes Gut Immune Homeostasis.
Wang G; Wang Q; Bai J; Zhao N; Wang Y; Zhou R; Kong W; Zeng T; Tao K; Wang G; Xia Z
Obes Surg; 2020 Jan; 30(1):327-335. PubMed ID: 31602628
[TBL] [Abstract][Full Text] [Related]
22. Fecal Metabolome and Bacterial Composition in Severe Obesity: Impact of Diet and Bariatric Surgery.
Salazar N; Ponce-Alonso M; Garriga M; Sánchez-Carrillo S; Hernández-Barranco AM; Redruello B; Fernández M; Botella-Carretero JI; Vega-Piñero B; Galeano J; Zamora J; Ferrer M; de Los Reyes-Gavilán CG; Del Campo R
Gut Microbes; 2022; 14(1):2106102. PubMed ID: 35903014
[TBL] [Abstract][Full Text] [Related]
23. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters.
Graessler J; Qin Y; Zhong H; Zhang J; Licinio J; Wong ML; Xu A; Chavakis T; Bornstein AB; Ehrhart-Bornstein M; Lamounier-Zepter V; Lohmann T; Wolf T; Bornstein SR
Pharmacogenomics J; 2013 Dec; 13(6):514-22. PubMed ID: 23032991
[TBL] [Abstract][Full Text] [Related]
24. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers.
Furet JP; Kong LC; Tap J; Poitou C; Basdevant A; Bouillot JL; Mariat D; Corthier G; Doré J; Henegar C; Rizkalla S; Clément K
Diabetes; 2010 Dec; 59(12):3049-57. PubMed ID: 20876719
[TBL] [Abstract][Full Text] [Related]
25. A Subset of Roux-en-Y Gastric Bypass Bacterial Consortium Colonizes the Gut of Nonsurgical Rats without Inducing Host-Microbe Metabolic Changes.
Liu Z; Coales I; Penney N; McDonald JAK; Phetcharaburanin J; Seyfried F; Li JV
mSystems; 2020 Dec; 5(6):. PubMed ID: 33293406
[TBL] [Abstract][Full Text] [Related]
26. Differential Changes in Gut Microbiota After Gastric Bypass and Sleeve Gastrectomy Bariatric Surgery Vary According to Diabetes Remission.
Murphy R; Tsai P; Jüllig M; Liu A; Plank L; Booth M
Obes Surg; 2017 Apr; 27(4):917-925. PubMed ID: 27738970
[TBL] [Abstract][Full Text] [Related]
27. The family Coriobacteriaceae is a potential contributor to the beneficial effects of Roux-en-Y gastric bypass on type 2 diabetes.
Liu H; Zhang H; Wang X; Yu X; Hu C; Zhang X
Surg Obes Relat Dis; 2018 May; 14(5):584-593. PubMed ID: 29459013
[TBL] [Abstract][Full Text] [Related]
28. Gastric bypass surgery in a rat model alters the community structure and functional composition of the intestinal microbiota independently of weight loss.
Haange SB; Jehmlich N; Krügel U; Hintschich C; Wehrmann D; Hankir M; Seyfried F; Froment J; Hübschmann T; Müller S; Wissenbach DK; Kang K; Buettner C; Panagiotou G; Noll M; Rolle-Kampczyk U; Fenske W; von Bergen M
Microbiome; 2020 Feb; 8(1):13. PubMed ID: 32033593
[TBL] [Abstract][Full Text] [Related]
29. Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity.
Münzker J; Haase N; Till A; Sucher R; Haange SB; Nemetschke L; Gnad T; Jäger E; Chen J; Riede SJ; Chakaroun R; Massier L; Kovacs P; Ost M; Rolle-Kampczyk U; Jehmlich N; Weiner J; Heiker JT; Klöting N; Seeger G; Morawski M; Keitel V; Pfeifer A; von Bergen M; Heeren J; Krügel U; Fenske WK
Microbiome; 2022 Jun; 10(1):96. PubMed ID: 35739571
[TBL] [Abstract][Full Text] [Related]
30. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery.
Aron-Wisnewsky J; Prifti E; Belda E; Ichou F; Kayser BD; Dao MC; Verger EO; Hedjazi L; Bouillot JL; Chevallier JM; Pons N; Le Chatelier E; Levenez F; Ehrlich SD; Dore J; Zucker JD; Clément K
Gut; 2019 Jan; 68(1):70-82. PubMed ID: 29899081
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of Roux-en-Y gastric bypass surgery on brown and beige adipose tissue thermogenesis.
Hankir MK; Bronisch F; Hintschich C; Krügel U; Seyfried F; Fenske WK
Metabolism; 2015 Oct; 64(10):1240-9. PubMed ID: 26211711
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
33. Roux-en-Y gastric bypass-induced bacterial perturbation contributes to altered host-bacterial co-metabolic phenotype.
Li JV; Ashrafian H; Sarafian M; Homola D; Rushton L; Barker G; Cabrera PM; Lewis MR; Darzi A; Lin E; Gletsu-Miller NA; Atkin SL; Sathyapalan T; Gooderham NJ; Nicholson JK; Marchesi JR; Athanasiou T; Holmes E
Microbiome; 2021 Jun; 9(1):139. PubMed ID: 34127058
[TBL] [Abstract][Full Text] [Related]
34. A single, peri-operative antibiotic can persistently alter the post-operative gut microbiome after Roux-en-Y gastric bypass.
Fernando DG; Saravia FL; Atkinson SN; Barron M; Kirby JR; Kindel TL
Surg Endosc; 2023 Feb; 37(2):1476-1486. PubMed ID: 35768736
[TBL] [Abstract][Full Text] [Related]
35. Gut Microbial Predictors of Type 2 Diabetes Remission Following Bariatric Surgery.
Davies N; O'Sullivan JM; Plank LD; Murphy R
Obes Surg; 2020 Sep; 30(9):3536-3548. PubMed ID: 32447634
[TBL] [Abstract][Full Text] [Related]
36. Reply to C Matuchansky.
Doré J; Clément K
Am J Clin Nutr; 2014 Mar; 99(3):650-1. PubMed ID: 24557536
[No Abstract] [Full Text] [Related]
37. Temporospatial shifts in the human gut microbiome and metabolome after gastric bypass surgery.
Ilhan ZE; DiBaise JK; Dautel SE; Isern NG; Kim YM; Hoyt DW; Schepmoes AA; Brewer HM; Weitz KK; Metz TO; Crowell MD; Kang DW; Rittmann BE; Krajmalnik-Brown R
NPJ Biofilms Microbiomes; 2020 Mar; 6(1):12. PubMed ID: 32170068
[TBL] [Abstract][Full Text] [Related]
38. Roux-en-Y gastric bypass and sleeve gastrectomy induce substantial and persistent changes in microbial communities and metabolic pathways.
Dang JT; Mocanu V; Park H; Laffin M; Hotte N; Karmali S; Birch DW; Madsen KL
Gut Microbes; 2022; 14(1):2050636. PubMed ID: 35316158
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota changes after metabolic surgery in adult diabetic patients with mild obesity: a randomised controlled trial.
Lau E; Belda E; Picq P; Carvalho D; Ferreira-Magalhães M; Silva MM; Barroso I; Correia F; Vaz CP; Miranda I; Barbosa A; Clément K; Doré J; Freitas P; Prifti E
Diabetol Metab Syndr; 2021 May; 13(1):56. PubMed ID: 34020709
[TBL] [Abstract][Full Text] [Related]
40.
Dao MC; Belda E; Prifti E; Everard A; Kayser BD; Bouillot JL; Chevallier JM; Pons N; Le Chatelier E; Ehrlich SD; Doré J; Aron-Wisnewsky J; Zucker JD; Cani PD; Clément K
Am J Physiol Endocrinol Metab; 2019 Sep; 317(3):E446-E459. PubMed ID: 31265324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
